VERTEX PHARMACEUTICALS INC / MA: operating_income
| Value | {"amount": -232900000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2024-01-01 – 2024-12-31 |
| Status | current |
| Entity | VERTEX PHARMACEUTICALS INC / MA |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:42:26.282054+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/38e4ec50-34fb-4cab-bc39-8e2e0068f13a
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000875320-25-000053Retrieved: 2026-08-19T08:42:26.282054+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000875320/operating-income/2024-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/38e4ec50-34fb-4cab-bc39-8e2e0068f13a
History
- no predecessors — first report